Lock-in programs connect patients to drug treatment, but don’t reduce risk of opioid overdose
September 17, 2019 Lock-in programs for individuals at risk for opioid misuse appear to have little effect on overdoses — a finding that points to a need for improved program design.
Hursting moves into 16th year of Breast Cancer Research Foundation grant
September 13, 2019 “Our work has evolved from asking Is obesity increasing cancer risk? and What are the mechanisms linking obesity and cancer?” Dr. Hursting says. “We have largely answered the first question and are still working on the second, but our focus really has turned to What are we going to do about it?”
Gillings School’s Alumni Board announces new members
September 13, 2019 The Gillings School's Alumni Association recently announced nine new members of its advising board. The board represents the more than 19,000 alumni of the School and meets quarterly with School leadership to address issues of importance to alumni and current students and to organize networking, professional development and social events.
Urland to lead NC Institute for Public Health
September 12, 2019 Douglas W. Urland has been named director of the North Carolina Institute for Public Health, effective November 4. “Doug’s recruitment is a tremendous plus for NCIPH,” said Dean Barbara K. Rimer.
Wajda recognized in Association for Healthcare Philanthropy’s '40 Under 40' list
September 4, 2019 Sara Wajda, assistant director of development on the advancement team at the Gillings School, has been named to the Association for Healthcare Philanthropy's 2019 '40 Under 40' list.
Weston, Gillings alumna, named among 'most admired CEOs'
September 4, 2019 Dana Weston, a UNC Gillings alumna, has been the president and CEO of UNC Rockingham Health Care in Eden, North Carolina, since 2015.
FDA approves breakthrough drug to treat Extensively Drug-Resistant Tuberculosis
September 4, 2019 Recently, the FDA announced its approval of pretomanid, a new drug developed to treat Extensively Drug-Resistant Tuberculosis (XDR-TB) and treatment intolerant/non-responsive Multidrug-Resistant (MDR) TB. Pretomanid is only the third anti-TB drug approved by the FDA in more than 40 years.
New peanut allergy treatment is effective and safe, study finds
September 4, 2019 UNC researchers show that tiny under-the-tongue doses of peanut protein can offer safe and substantial protection against a peanut allergy.
Sharing breast milk is increasingly common, but its impact on infant nutrition is understudied
September 4, 2019 Though many families worldwide turn to various methods of human milk exchange to feed and nourish their infants, researchers have done little to explore the impact of sharing breast milk on infant health outcomes and malnutrition.
Gillings students cross international and disciplinary borders in the Galápagos
September 3, 2019 Over the summer, students and faculty from the Gillings School joined forces with colleagues from Universidad San Francisco de Quito to conduct a study on water and food insecurity in the Galápagos Islands of Ecuador.
